These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16539845)

  • 1. High-throughput fluorescence polarization method for identifying ligands of LOX-1.
    Zhang TT; Huang ZT; Dai Y; Chen XP; Zhu P; Du GH
    Acta Pharmacol Sin; 2006 Apr; 27(4):447-52. PubMed ID: 16539845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
    Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
    Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of recombinant human LOX-1 and identifying its mimic ligands by fluorescence polarization-based high throughput screening.
    Zhang T; Huang Z; Dai Y; Chen X; Zhu P; Du G
    J Biotechnol; 2006 Oct; 125(4):492-502. PubMed ID: 16735073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.
    Chen X; Zhang T; Du G
    Cell Biochem Funct; 2008 Oct; 26(7):760-70. PubMed ID: 18636435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput fluorescent polarization assay for nuclear receptor binding utilizing crude receptor extract.
    Lin S; Bock CL; Gardner DB; Webster JC; Favata MF; Trzaskos JM; Oldenburg KR
    Anal Biochem; 2002 Jan; 300(1):15-21. PubMed ID: 11743686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
    Harris A; Cox S; Burns D; Norey C
    J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).
    Ishigaki T; Ohki I; Utsunomiya-Tate N; Tate SI
    J Biochem; 2007 Jun; 141(6):855-66. PubMed ID: 17416594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cells.
    Catar RA; Müller G; Heidler J; Schmitz G; Bornstein SR; Morawietz H
    Horm Metab Res; 2007 Nov; 39(11):801-5. PubMed ID: 17992634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone decreased CD40/CD40L expression on human umbilical vein endothelial cells induced by oxidized low-density lipoprotein.
    Jiang DQ; Chu LX; Liu ZY; Zhang SB
    Clin Chim Acta; 2006 Aug; 370(1-2):94-9. PubMed ID: 16545355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM; Du GH
    Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays.
    Parker GJ; Law TL; Lenoch FJ; Bolger RE
    J Biomol Screen; 2000 Apr; 5(2):77-88. PubMed ID: 10803607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flow-through fluorescence polarization detection system for measuring GPCR-mediated modulation of cAMP production.
    Kool J; van Marle A; Hulscher S; Selman M; van Iperen DJ; van Altena K; Gillard M; Bakker RA; Irth H; Leurs R; Vermeulen NP
    J Biomol Screen; 2007 Dec; 12(8):1074-83. PubMed ID: 18087072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy.
    Nowicki M; Zabirnyk O; Duerrschmidt N; Borlak J; Spanel-Borowski K
    Eur J Cell Biol; 2007 Oct; 86(10):605-16. PubMed ID: 17643551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomerization is required for the activity of recombinant soluble LOX-1.
    Cao W; Calabro V; Root A; Yan G; Lam K; Olland S; Sanford J; Robak A; Zollner R; Lu Z; Ait-Zahra M; Agostinelli R; Tchistiakova L; Gill D; Harnish D; Paulsen J; Shih HH
    FEBS J; 2009 Sep; 276(17):4909-20. PubMed ID: 19664054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorescence polarization assay for screening inhibitors against the ribonuclease H activity of HIV-1 reverse transcriptase.
    Nakayama GR; Bingham P; Tan D; Maegley KA
    Anal Biochem; 2006 Apr; 351(2):260-5. PubMed ID: 16527235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin-like oxidized low-density lipoprotein receptor (LOX-1) functions as an oligomer and oligomerization is dependent on receptor density.
    Matsunaga S; Xie Q; Kumano M; Niimi S; Sekizawa K; Sakakibara Y; Komba S; Machida S
    Exp Cell Res; 2007 Apr; 313(6):1203-14. PubMed ID: 17306253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay.
    Wang L; Bao Y; Yang Y; Wu Y; Chen X; Si S; Hong B
    J Biomol Screen; 2010 Mar; 15(3):239-50. PubMed ID: 20150587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.